Citius Pharma Q1 EPS $(0.06) Down From $(0.02) YoY
Author: Happy Mohamed | February 14, 2024 06:14pm
Citius Pharma (NASDAQ:CTXR) reported quarterly losses of $(0.06) per share. This is a 200 percent decrease over losses of $(0.02) per share from the same period last year.